NASDAQ · COEPW
Healthcare · Biotechnology
$0.01
Up+$0.00 (+0.00%)
Updated Aug 18, 2026, 5:02 PM
SID Score
2.8/10
Composite research score
Smart Money
—
Institutional and insider signal
Price performance
1M range · 0 trading sessions · Daily adjusted prices
COEPW does not have enough price history for the selected period.
Data unavailable
The requested market data was not found.
The latest Smart Investors Daily articles mentioning COEPW.
COEPW research
Company profile and research snapshot.
Coeptis Therapeutics Holdings Inc is a biopharmaceutical company developing cell therapy platforms for patients with cancer. The company's product portfolio consists of multi-antigen CAR T technology licensed from the University of Pittsburgh (SNAP-CAR), a cell therapy technology (CD38-GEAR-NK), and an in vitro diagnostic (CD38-Diagnostic) targeting CD38-related cancers, which the company is developing with VyGen-Bio and medical researchers at the Karolinska Institutet.
Visit company websiteConsensus and target data currently published for this company.
No generated briefing is available yet.
Benzinga · Jun 26, 2025
Coeptis Therapeutics has filed a registration statement with the SEC regarding a proposed merger with Z Squared Inc., a digital asset compute mining company. The Form S-4 includes a preliminary proxy statement/prospectus about the transaction.
GlobeNewswire Inc. · Feb 19, 2025
COEPTIS and MarketLeverage have partnered to integrate AI technology with performance-based affiliate marketing strategies, aiming to provide advanced automation, data-driven insights, and seamless campaign optimization for affiliates, brands, and marketers.
Benzinga · Jan 23, 2025
Coeptis Therapeutics is expanding its technological initiatives to include artificial intelligence and blockchain solutions, aiming to enhance operational efficiency and drive innovation in the pharmaceutical industry.
Benzinga · Dec 27, 2024
Coeptis Therapeutics announced a 1-for-20 reverse stock split to help meet the minimum bid price requirement for maintaining its Nasdaq Capital Market listing.
Interpretive context generated from the platform’s current data sources.
No results
AI research layers have not been published yet.
The latest Smart Investors Daily articles mentioning COEPW.
No results
No recent SID articles mention COEPW.
